Lawmakers slam slow progress on UK drug pricing overhaul

LONDON (Reuters) – British lawmakers have criticized the government’s failure to detail a new system for medicines pricing that is due to be introduced next January, saying lack of clarity is creating uncertainty for industry and doctors. The House of Commons Health Committee called on the government on Wednesday to make clear its plans by the end of March 2013. “There has been extensive discussion of the principle of value-based pricing but it remains a source of concern that so little progress has been made on defining this nebulous concept,” the committee said in a report. …